The FinancialContent Network     SocialPicks Community   |   MarketMinute Monitor   |   MarketMinute Market Updates   |   MarketMinute Stock News
SocialPicks
   Sign Up   |   Log In   |   What is SocialPicks?     
6 pts

Opinion on  Spectrum Pharmaceuticals Inc. (SPPI)     Sector: Healthcare  >  Industry: Biotechnology & Drugs
RECENT NEWS

Sep 10, 2009 03:25 AM GMT
Return Risk
-3.07% LOW
Sr. Analyst

spectrum Pharma tgt raised to $10 at Rodman & Renshaw following FDA approval for the expanded label of Zevalin Rodman & Renshaw raise their SPPI tgt to $10 from $8 following the FDA approval for an expanded label of Zevalin, which treats the previously untreated follicular non-Hodgkin's Lymphoma. With the label expansion, the treatable population expands from 6,000 to potentially 43,000 patients annually, in the firm's opinion.

SPPI:  This call was made on 09/10/09 @ $7.3
Rating:   Positive   $7.3 (09/10/09)
Gain/Loss:   -34.11% in 88 days
Target:   $10.00 (+36.99%) in One month


Add Comment

Be the first to comment on this story and earn 2 points.

Your Comment



ROCK-STAR INVESTORS
Rank Name Sharpe Ratio Avg Return Followers
1 noshoes 21.10 +34.44% 381
2 Gerald Greene 18.14 +71.24% 211
3 stockmarketfunding.com 17.66 +25.60% 55
4 akiralegrand 13.47 +14.32% 62
5 anup2104 12.13 +74.22% 40


POPULAR STOCKS
Symbol Company Name Sentiment
POT Potash Corp. of Saskatchewan Inc.
MA MasterCard Inc
XOM Exxon Mobil Corp
KO The CocaCola Company
MO Altria Group Inc
GOOG Google Inc

TODAY'S HEADLINES

TODAY'S TOP PICKS

 
Spectrum Pharmaceuticals Inc. (SPPI)
   SocialPicks Sentiment:   

   This Quarter's Sentiment:
All:
84.5%
Top:
100.0%




Latest Picks by Olof Thomas
Symbol SP Sentiment Rating Return Since
IFON N/A Positive -29.35% 09/23/09
EDAP N/A Positive -24.89% 09/23/09
CVM Positive -5.30% 09/17/09
BGZ Positive -12.37% 09/17/09
SXCI N/A Positive +20.97% 09/09/09

View All >
   
Olof Thomas previously rated SPPI
Positive +1.53% Recent News
09/09/2009
1
Positive -13.69% Techical Analysis
09/08/2009
1





IN THE PRESS
Press_forbes Press_washingtonpost Press_wsj Press_npr Press_techcrunch